{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:34:42Z","timestamp":1789918482463,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ejogrb.2012.06.010","type":"journal-article","created":{"date-parts":[[2012,7,7]],"date-time":"2012-07-07T21:37:35Z","timestamp":1341697055000},"page":"167-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Follicular fluid concentrations of IGF-I, IGF-II, IGFBP-3, VEGF, AMH, and inhibin-B in women undergoing controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist"],"prefix":"10.1016","volume":"164","author":[{"given":"Aysenur","family":"Kaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem S.","family":"Atabekoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korhan","family":"Kahraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salih","family":"Taskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batuhan","family":"Ozmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bulent","family":"Berker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Sonmezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2012.06.010_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.anireprosci.2004.04.031","article-title":"Follicular development: the role of the follicular microenvironment in selection of the dominant follicle","volume":"82\/3","author":"Fortune","year":"2004","journal-title":"Animal Reproduction Science"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0010","first-page":"26","article-title":"Insulin-like growth factor family in Graafian follicle development and function","volume":"8","author":"Giudice","year":"2001","journal-title":"Journal of the Society for Gynecologic Investigation"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0303-7207(99)00244-0","article-title":"Importance of the IGF in early folliculogenesis","volume":"163","author":"Monget","year":"2000","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0020","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1023656225053","article-title":"Inhibin B predicts oocyte number and the ratio IGF-I\/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization","volume":"20","author":"Fried","year":"2003","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0025","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/humrep\/del091","article-title":"Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients","volume":"21","author":"Choi","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0030","first-page":"1411","article-title":"Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary","volume":"77","author":"el-Roeiy","year":"1993","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0035","first-page":"419","article-title":"Expression of the genes encoding the insulin-like growth factors and their receptors in the human ovary","volume":"74","author":"Hernandez","year":"1992","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0040","first-page":"1224","article-title":"Serum and follicular fluid levels of insulin-like growth factor I (IGF-I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle","volume":"81","author":"van Dessel","year":"1996","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1677\/joe.0.1780177","article-title":"IGF-binding protein-4: biochemical characteristics and functional consequences","volume":"178","author":"Zhou","year":"2003","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0050","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.fertnstert.2006.03.064","article-title":"Insulin-like growth factor-II (IGF-II), IGF-binding protein-3 (IGFBP-3), and IGFBP-4 in follicular fluid are associated with oocyte maturation and embryo development","volume":"86","author":"Wang","year":"2006","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0055","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1210\/edrv-13-1-18","article-title":"Molecular and biological properties of the vascular endothelial growth factor family of proteins","volume":"13","author":"Ferrara","year":"1992","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/09513590600777602","article-title":"Gonadotropin-releasing hormone antagonists increase follicular fluid insulin-like growth factor-I and vascular endothelial growth factor during ovarian stimulation cycles","volume":"22","author":"Ferrari","year":"2006","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0065","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0015-0282(98)00301-X","article-title":"Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential","volume":"70","author":"Friedman","year":"1998","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0070","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0015-0282(00)01517-X","article-title":"Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders","volume":"74","author":"Battaglia","year":"2000","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2004.01.034","article-title":"Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome?","volume":"115","author":"Ocal","year":"2004","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0080","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0015-0282(99)00442-2","article-title":"Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients","volume":"72","author":"Barroso","year":"1999","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0085","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-mullerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0090","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0015-0282(01)03201-0","article-title":"Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0095","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.fertnstert.2004.03.061","article-title":"Serum antimullerian hormone\/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol","volume":"82","author":"Hazout","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0100","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/humrep\/dei203","article-title":"Dynamic assays of inhibin B, anti-mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0105","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1210\/endo.142.11.8486","article-title":"Anti-mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary","volume":"142","author":"Durlinger","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0110","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0303-7207(98)00186-5","article-title":"The role of anti-mullerian hormone in gonadal development","volume":"145","author":"Josso","year":"1998","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0120","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.fertnstert.2006.08.102","article-title":"Comparison of preovulatory follicular concentrations of epidermal growth factor, insulin-like growth factor-I, and inhibins A and B in women undergoing assisted conception treatment with gonadotropin-releasing hormone (GnRH) agonists and GnRH antagonists","volume":"87","author":"Ulug","year":"2007","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/molehr\/7.4.319","article-title":"Gonadotrophins inhibit and activin induces expression of inhibin\/activin beta(B) subunit mRNA in cultured human granulosa-luteal cells","volume":"7","author":"Liu","year":"2001","journal-title":"Molecular Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mce.2004.02.011","article-title":"Inhibins and adult ovarian function","volume":"225","author":"Laven","year":"2004","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0135","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/humrep\/17.7.1724","article-title":"The concentration of inhibin B in follicular fluid: relation to oocyte maturation and embryo development","volume":"17","author":"Chang","year":"2002","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0140","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.375393","article-title":"Extrapituitary action of gonadotropin-releasing hormone: direct inhibition ovarian steroidogenesis","volume":"204","author":"Hsueh","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-291X(92)91556-6","article-title":"Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor","volume":"189","author":"Kakar","year":"1992","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"Suppl 1","key":"10.1016\/j.ejogrb.2012.06.010_bib0150","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/humrep\/14.suppl_1.194","article-title":"Pituitary and extrapituitary actions of gonadotrophin-releasing hormone and its analogues","volume":"14","author":"Ortmann","year":"1999","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/molehr\/5.3.234","article-title":"GnRH mRNA and protein expression in human preimplantation embryos","volume":"5","author":"Emons","year":"1999","journal-title":"Molecular Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0160","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1210\/endo.135.5.7956897","article-title":"Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells","volume":"135","author":"Peng","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0165","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1210\/endo.141.1.7250","article-title":"Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium","volume":"141","author":"Kang","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0170","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1210\/endo.142.2.7982","article-title":"Estradiol regulates gonadotropin-releasing hormone (GnRH) and its receptor gene expression and antagonizes the growth inhibitory effects of GnRH in human ovarian surface epithelial and ovarian cancer cells","volume":"142","author":"Kang","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0175","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0180","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/j.fertnstert.2008.03.057","article-title":"Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle","volume":"91","author":"Kahraman","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/6.5.505","article-title":"Direct ovarian effects and safety aspects of GnRH agonists and antagonists","volume":"6","author":"Janssens","year":"2000","journal-title":"Human Reproduction Update"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0190","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/1933719107310707","article-title":"Gonadotropin-releasing hormone in the ovary","volume":"14","author":"Metallinou","year":"2007","journal-title":"Reproductive Sciences"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0195","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/humrep\/15.7.1490","article-title":"Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial","volume":"15","author":"Borm","year":"2000","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(00)01638-1","article-title":"Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation","volume":"75","author":"Fluker","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0205","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"5","author":"Al-Inany","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0210","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00404-001-0267-2","article-title":"Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis","volume":"265","author":"Ludwig","year":"2001","journal-title":"Archives of Gynecology and Obstetrics"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0215","first-page":"CD001750","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","volume":"3","author":"Al-Inany","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1472-6483(10)62054-8","article-title":"Gonadotrophin-releasing hormone antagonists: will they replace the agonists?","volume":"6","author":"Felberbaum","year":"2003","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1530\/eje.0.1490031","article-title":"Actions of GnRH antagonists on IGF-II. IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells","volume":"149","author":"Weiss","year":"2003","journal-title":"European Journal of Endocrinology\/European Federation of Endocrine Societies"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0230","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/eje.0.1440677","article-title":"Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells","volume":"144","author":"Weiss","year":"2001","journal-title":"European Journal of Endocrinology\/European Federation of Endocrine Societies"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0235","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/S0015-0282(00)01552-1","article-title":"Effect of the gonadotropin-releasing hormone antagonist ganirelix on cyclic adenosine monophosphate accumulation of human granulosa-lutein cells","volume":"74","author":"Demirel","year":"2000","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0240","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/humrep\/12.4.769","article-title":"Specific gonadotrophin-releasing hormone analogue binding predominantly in human luteinized follicular aspirates and not in human pre-ovulatory follicles","volume":"12","author":"Brus","year":"1997","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0245","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF03344118","article-title":"IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol","volume":"29","author":"Asimakopoulos","year":"2006","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0250","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.fertnstert.2006.01.046","article-title":"Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures","volume":"86","author":"Asimakopoulos","year":"2006","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0255","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/humrep\/del207","article-title":"Cytokine and hormonal profile in blood serum and follicular fluids during ovarian stimulation with the multidose antagonist or the long agonist protocol","volume":"21","author":"Asimakopoulos","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0260","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.fertnstert.2007.04.010","article-title":"Follicular fluid anti-m\u00fcllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles","volume":"89","author":"Lee","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0265","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.fertnstert.2009.09.032","article-title":"Gonadotropin releasing hormone antagonists suppress aromatase and anti-Mullerian hormone expression in human granulosa cells","volume":"94","author":"Winkler","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0270","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.fertnstert.2007.03.080","article-title":"Anti-mullerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization","volume":"89","author":"Takahashi","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0275","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1210\/jc.2006-1053","article-title":"Anti-mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization","volume":"92","author":"Fanchin","year":"2007","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0280","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.fertnstert.2007.10.078","article-title":"Anti-mullerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization\/intracytoplasmic sperm injection","volume":"90","author":"Wunder","year":"2008","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0285","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.fertnstert.2009.03.004","article-title":"Increased anti-mullerian hormone and decreased FSH levels in follicular fluid obtained in women with polycystic ovaries at the time of follicle puncture for in vitro fertilization","volume":"94","author":"Desforges-Bullet","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0290","first-page":"604","article-title":"Correlations between anti-mullerian hormone, inhibin B, and activin A in follicular fluid in IVF\/ICSI patients for assessing the maturation and developmental potential of oocytes","volume":"12","author":"Cupisti","year":"2007","journal-title":"European Journal of Medical Research"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0295","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/humrep\/13.2.285","article-title":"Insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations in fluid from human stimulated follicles","volume":"13","author":"Oosterhuis","year":"1998","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.06.010_bib0300","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10815-011-9543-7","article-title":"The effect of intrafollicular IGF 1 and IGFBP 3 on IVF outcome in patients using different gonadotropins: a prospective study","volume":"28","author":"Genc","year":"2011","journal-title":"Journal of Assisted Reproduction and Genetics"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211512002771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211512002771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:26:21Z","timestamp":1759555581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211512002771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0301211512002771"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.06.010","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follicular fluid concentrations of IGF-I, IGF-II, IGFBP-3, VEGF, AMH, and inhibin-B in women undergoing controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}